Just a few days after learning about the growing investment figures for 2019 in the life sciences and healthcare sector in Catalonia, the venture capital firms Alta Life Sciences and Asabys, both with headquarters in Barcelona, have announced two rounds in start-ups worth €5.8M.

The Catalan start-up DeepUll, created by Jordi Carrera and Rafael Bru (ex-founders of STAT-Dx), has raised €3.5M to validate their platform for early septicaemia detection. Alta Life Sciences and Kurma Partners led this round.

Furthermore, Origo Biopharma, founded in Galicia by GalChimia and Julio Castro (founder of Palobiofarma) and managed by Ramon Bosser (ex-founder of Spherium Biomed), has received €2.3M to help get their medication for treating patients with fibrosis associated with Crohn’s disease to clinical trials. Asabys led the capital injection and their partner Clara Campàs was appointed chairwoman of the Board of Directors of Origo.

Further information available from Ara newspaper (in Catalan).